VOLUNTEERS

People_Annabelle_01.jpg

Annabelle Hall

Annabelle joined the quest for a cure for Crohn’s disease in September 2014 after her son was diagnosed. She watched as her son’s condition quickly deteriorated and feared for his future. Refusing to accept that no cure was possible, she dove into research. Highly committed to helping find a cure, she has been deeply involved in raising awareness and funds for promising research including the Crohn’s MAP Vaccine.  In addition, she was the Special Events coordinator for Human Para Foundation. She has strong faith in the power of science and firmly believes that by providing financial support to innovative scientists, a cure is within grasp. Fluent in French, she spent most of her professional career as a high school teacher in Africa, France, Asia and the U.S. She has a B.A. in Cultural Anthropology and History from the University of California, San Diego and an M.A with Honors in Leadership from Saint Mary’s College of California.

People_Angela_01a.jpg

Angela Clark

Originally from Georgia, Angela received her B.A. in political science from Maryville College (TN) and her master’s degree in Western European government and politics from the London School of Economics and Political Science. In the past, she enjoyed a career in the federal government and also worked in local radio and television. Most recently, she served as a marketing director at a private school. She and her husband have a son and a daughter. Angela became involved in Propel a Cure after the Crohn’s diagnosis of a relative and is passionate about supporting innovative research that pushes beyond the current therapy landscape to ultimately lead us to a cure.

People_Ildiko_01a.jpg

Ildiko Mehes

Ildiko is a consultant to the pharmaceutical industry and to the broader investor community related to the pharmaceutical and healthcare sectors. Ildiko is a former SVP & General Counsel of Teva Pharmaceuticals and is an attorney licensed in the State of Massachusetts and in Canada. Ildiko has close family and friends who suffer from Crohn’s disease and is deeply committed to driving research that will yield clinically meaningful answers to currently unanswered questions or gaps in our understanding of the pathogenesis and progression of Crohn’s disease.

People_Gout_02a.jpg

Antony Gout, MD

Antony is currently a resident physician at the University of Iowa. He graduated from Carver College of Medicine, University of Iowa in 2020 and in 2013 he graduated from UCLA with a BS in Molecular Cell and Developmental Biology. He was diagnosed with Crohn’s disease mid-2014. Having experienced the ravages of the disease himself, he has every reason to support innovative research that will help lead us to a cure.

People_Natalie_01b.jpg

Natalie Muccioli Emery, RDH BHA

Natalie is a healthcare professional with experience in dental hygiene, health administration and health promotion in Canada. Joining Propel a Cure is deeply personal to Natalie. She has struggled with gastrointestinal symptoms for 26 years and received an official Crohn’s Disease diagnosis in 2011 after requiring emergency major surgery. Natalie also has a sister with Crohn’s Disease. Reinforced by her background in disease prevention and health promotion, Natalie firmly believes that through coordination, collaboration, and sound investment in research; better treatment options for, and even prevention of Crohn’s Disease are real possibilities.

People_Kelly_01b.jpg

Kelly Owens

Kelly is a patient advocacy consultant to the emerging field of bioelectronic medicine, working with the Feinstein Institutes for Medical Research, SetPoint Medical, and other pioneers in the field. After failing 22 biologics and DMARDs, Kelly participated in a clinical trial for vagus nerve stimulation, putting her Crohn’s disease and inflammatory arthritis into remission for the first time since her diagnosis 15 years prior. Determined to make this field more accessible, Kelly came home from her clinical trial and got to work, supporting efforts to advance research, educate about the field and its potential to transform lives and upend the paradigm of sick-care, and expand access to more patients. Patients who are interested in learning more about bioelectronic medicine should email Kelly at kowens4@northwell.edu.